Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 0.91B P/E 8.03 EPS this Y -226.00% Ern Qtrly Grth -
Income -71.96M Forward P/E -13.13 EPS next Y 33.70% 50D Avg Chg 15.00%
Sales 163.87M PEG - EPS past 5Y - 200D Avg Chg 52.00%
Dividend N/A Price/Book 2.75 EPS next 5Y - 52W High Chg -10.00%
Recommedations 1.60 Quick Ratio 3.10 Shares Outstanding 27.04M 52W Low Chg 162.00%
Insider Own 8.47% ROA -13.60% Shares Float 24.74M Beta 2.61
Inst Own 93.03% ROE -26.47% Shares Shorted/Prior 5.23M/5.46M Price 34.14
Gross Margin -18.43% Profit Margin -43.92% Avg. Volume 429,335 Target Price 69.11
Oper. Margin -42.37% Earnings Date Nov 12 Volume 328,376 Change -2.23%
About Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. Its product pipeline includes, ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3; ARCT-2303 for monovalent that is in Phase 3; ARCT-2138 for quadrivalent which is in Phase 1; and LUNAR-FLU which is in pre-clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Arcturus Therapeutics Holdings News
11/18/24 Arcturus Therapeutics to Present at Jefferies London Healthcare Conference
11/14/24 Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
11/11/24 Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
11/09/24 Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations
11/08/24 Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call
11/08/24 Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ...
11/07/24 Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates
11/07/24 Arcturus Therapeutics: Q3 Earnings Snapshot
11/07/24 Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
11/04/24 Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect
10/31/24 Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
10/30/24 Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock?
10/24/24 Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain
10/23/24 A slow start for self-amplifying mRNA vaccines
10/01/24 ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
09/30/24 Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
09/30/24 Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
09/16/24 Here's Why Investors Should Invest in Arcturus Stock Now
09/13/24 Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
ARCT Chatroom

User Image cielo1 Posted - 56 minutes from now

$MRNA a red close this month to a red year-end rotation is in full swing through-year end. Wall street has left and is leaving the building. Entire mRNA sector sentiment has changed significantly and will not recover. Too much new cleaner effective actual vaccine technology, mRNA is passe and has left a huge negative impression legacy across the globe! Billions were told they would not catch c19 after taking the injections only to catch c19 multiple multiple times. Common sense eventually catches up with everything. Time tells all! $PFE $BNTX $ARCT

User Image WaspofWallStreet Posted - 21 minutes ago

$ARCT taking a look it, was very good to me about a year ago. May jump back in.

User Image Dr_My Posted - 3 hours ago

$ARCT how low will they take this? $10?

User Image Docm26 Posted - 5 hours ago

$ARCT locked in my 10k shares at a high sell order for February. 👍🏻

User Image tallguy777 Posted - 10 hours ago

$ARCT still on a downward trend...

User Image Dr_Feel_Good Posted - 15 hours ago

$ARCT just can’t catch a break after that pop yesterday. Leaving position in neutral weighting till we can break out of this funk.

User Image EQ55 Posted - 21 hours ago

$ARCT I'm so happy right now. The gift that keeps on giving. 300k share volume. I bought 50k shares so no volume at all. Shorts are so screwed whe we pull the trigger on 1 million shares.

User Image LionHippo Posted - 22 hours ago

$ARCT just a thought. A group buys up a bunch of shares causing the stock to rise considerably. They sell naked calls. They then sell the shares that they bought for a 20% profit. On top of which they short the f*** out of it because why not. They are controlling the price of the stock. The stock drops and they cover and close out all their short positions. Also they buy their calls that they sold for a much higher premium. I mean, you wouldn't need to buy that much. If you had $5mil to play with you could do this and double up your money every week. It's brilliant. It should be illegal but I promise you it's happening. And it's happening in this stock. I have had great luck with it, but as long as they can short 20% of the free float and almost 2000% of the daily volume, it's pointless to invest in this shit. I have been here a long time, there are much better companies that deserve my money.

User Image Joudat Posted - 22 hours ago

$ARCT I hate to break this, but now it's "clear" any rally here is bear market rally. Will it retest that $14.93 ?

User Image Joudat Posted - 22 hours ago

$ARCT renewed selling in vaccine stocks MRNA, NNTX, NVAX, CVAC and ARCT. Sounds still "toxic" sector to be, just when ARCT trying to make its commercial debut

User Image MaxCorona Posted - 22 hours ago

$ARCT didn’t want to buy more, but if we see 15…maybe.

User Image Joudat Posted - 23 hours ago

$ARCT Can we now agree about the outcome of London presentation? The stocks speaks for itself!

User Image Dr_My Posted - 1 day ago

$ARCT Classic ARCT action. Can't hold gains. Need some big catalysts

User Image MaxCorona Posted - 1 day ago

$ARCT lots of cooperations. A buyout from one of them will come sooner or later. Maybe faster than we expect…

User Image JudithKaur Posted - 1 day ago

$THRD $ARCT $EBS LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? đź‘€ And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image King316 Posted - 1 day ago

$ARCT we have the best mRNA Vaccine. Maybe you don’t care anymore about COVID. But you should understand what that means for the value of the platform Bullish, and not selling a singe share :-) https://www.meiji.com/global/news/2024/pdf/241119_01.pdf

User Image analysis_first Posted - 1 day ago

$ARCT $MRNA and $BNTX and $PFE should check out ARCT.

User Image analysis_first Posted - 1 day ago

$ARCT Enterprise Value is <$300mm for company with mRNA platform with superior approved drug in Japan, then maybe EU, then maybe US? What kind of person is short this company. Partner CSL prolly gonna try to buy them out for $50/shr.

User Image Capitalism_not_socialism Posted - 1 day ago

$ARCT https://childrenshealthdefense.org/defender/fda-trial-bird-flu-vaccine-gates-foundation/ Genocide shot.

User Image Dr_Feel_Good Posted - 2 days ago

$ARCT 👇 https://www.businesswire.com/news/home/20241118497441/en/Arcturus-Therapeutics-to-Present-at-Jefferies-London-Healthcare-Conference

User Image Dr_Feel_Good Posted - 2 days ago

$ARCT added here at $17.40. Increased risk weighting from 2.18% to 2.41% and dca position from $30 to $28.98.

User Image Docm26 Posted - 2 days ago

$ARCT picked up a couple thousand more on this drop. 👍🏻

User Image knitrade Posted - 2 days ago

$ARCT just opened a position, looks like very promising company with strong financials

User Image Dr_Feel_Good Posted - 3 days ago

$ARCT nice rebound from the lows last Friday. Hoping we can hold above $17 - will look to nibble again between $17-20 and dca below $30 if we stay in this range.

User Image MaxCorona Posted - 3 days ago

$ARCT I thought, this will stay around 20 for a few months. But never thought I would get the opportunity to buy around 15-16. 300 millions cash!

User Image MaxCorona Posted - 3 days ago

$ARCT maybe a few bad days, until everyone r3cognizes, that nothing has changed just because Trump has nominated a vaccination critical guy. The whole world still knows about the importance of it. And it could be more dangerous for companies, which are at the beginning of their research. We already are beyond that. Stay calm, buy. Like institutionals do!

User Image cielo1 Posted - 3 days ago

$ARCT $MRNA $BNTX $PFE The mRNA sub sector of the pharmaceutical sector/industry has fastly become a global referendum on the overall handling of the pandemic in general. Like it or not, as it is. Kindest regards to all!

User Image MaxCorona Posted - 3 days ago

$ARCT what should this bullshit have to do with ARCT? It’s because the woman was forced to get vaccinated. Not a problem of the vaccine. Shorts try everything.

User Image cielo1 Posted - 4 days ago

$ARCT $MRNA $PFE $BNTX the dam continues to crack... run as fast as you can from c19 injection manufacturers. https://www.detroitnews.com/story/news/local/michigan/2024/11/08/michigan-jury-awards-millions-to-woman-fired-after-refusing-to-get-covid-19-vaccine/76138093007/

User Image EQ55 Posted - 4 days ago

$ARCT what a gift

Analyst Ratings
Leerink Partners Outperform Aug 12, 24
HC Wainwright & Co. Buy Aug 8, 24
Cantor Fitzgerald Overweight Aug 6, 24
HC Wainwright & Co. Buy Jul 2, 24
Canaccord Genuity Buy May 10, 24
HC Wainwright & Co. Buy Mar 20, 24
Canaccord Genuity Buy Mar 11, 24
HC Wainwright & Co. Buy Mar 8, 24
Wells Fargo Overweight Mar 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Chivukula Pad Chief Scientific Off.. Chief Scientific Officer & COO Jul 14 Sell 35.01 25,000 875,250 519,448 07/18/23
Kummerfeld Keith C See Remarks See Remarks Jul 14 Sell 35 6,968 243,880 950 07/18/23
Kummerfeld Keith C See Remarks See Remarks Jul 14 Option 9.38 6,968 65,360 7,918 07/18/23
Chivukula Pad Chief Scientific Off.. Chief Scientific Officer & COO Jul 03 Sell 28.75 5,000 143,750 544,448 07/07/23
Kummerfeld Keith C See Remarks See Remarks Apr 17 Sell 28.18 6,968 196,358 950 04/19/23
Kummerfeld Keith C See Remarks See Remarks Apr 17 Option 9.38 6,968 65,360 7,918 04/19/23
Chivukula Pad Chief Scientific Off.. Chief Scientific Officer & COO Apr 03 Sell 25.38 5,000 126,900 584,448 04/05/23
Chivukula Pad Chief Scientific Off.. Chief Scientific Officer & COO Mar 06 Sell 16.07 5,000 80,350 589,448 03/08/23